Fig. 3
From: Clinical aspects of TP53 gene inactivation in diffuse large B-cell lymphoma
The sequenced fragments of DNA containing mutations of TP53. a: homozygote of p.L130F, b: a heterozygote of p.W146R, c1: a homozygote of p.T155I, c2: a heterozygote of p.T155I, d: a homozygote of p.R156C, e: a homozygote of р.V157 V, f: a homozygote of р.H179H, g: a homozygote of p.A189Pfs, h: a homozygote of p.R196Q, i: a heterozygote of p.R213Х, j: a heterozygote of p.G244S, k: a heterozygote of p.L252 L, l: a heterozygote of p.V272E, m: a heterozygote of р.V272 V, n: a heterozygote of p.A276V; o: a homozygote of p.G293R, p: a heterozygote of p.G302G, q: a heterozygote of р.A307A, r: a homozygote of IVS4-30Т > С, s: a homozygote of IVS5 + 43G > T, t: a heterozygote of IVS5-17Т > С, u: a heterozygote of IVS6-36G > C, v: a heterozygote of IVS7 + 31G > С, w: a heterozygote of IVS8 + 10С > А, x: a heterozygote of IVS8 + 20A > G, y: a heterozygote of IVS8 + 37A > G, and z: a heterozygote of IVS9 + 12Т > С